Skip to main content
Clinical Trials/JPRN-UMIN000028533
JPRN-UMIN000028533
Completed
未知

An observational validation study of the impact of Frailty on posttreatment adverse events and poor prognosis in patients with a patient with urological diseases - An observational validation study of the impact of Frailty on posttreatment adverse events and poor prognosis in patients with a patient with urological diseases

Hirosaki University Graduate School of Medicine0 sites559 target enrollmentAugust 6, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
rological diseases
Sponsor
Hirosaki University Graduate School of Medicine
Enrollment
559
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The FDS is a reliable and valid tool for assessing frailty and prognosis in patients with urological cancers.

Registry
who.int
Start Date
August 6, 2017
End Date
July 2, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hirosaki University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with urological diseases who could not undergo frailty assessments.

Outcomes

Primary Outcomes

Not specified

Similar Trials